Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

AF in Cancer Patients: A Different Need for Anticoagulation?

Sanz AP, Gómez JLZ.

Eur Cardiol. 2019 Apr;14(1):65-67. doi: 10.15420/ecr.2018.32.2. Review.

2.

Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression.

Restrepo C, Gutierrez-Rivas M, Pacheco YM, García M, Blanco J, Medrano LM, Navarrete-Muñoz MA, Gutiérrez F, Miralles P, Dalmau D, Gómez JL, Górgolas M, Cabello A, Resino S, Benito JM, Rallón N; CoRIS and the HIV Biobank integrated in the Spanish AIDS Research Network Project RIS/EPICLIN 10_2015.

PLoS One. 2019 Mar 28;14(3):e0214421. doi: 10.1371/journal.pone.0214421. eCollection 2019.

3.

Ultrapotent chemogenetics for research and potential clinical applications.

Magnus CJ, Lee PH, Bonaventura J, Zemla R, Gomez JL, Ramirez MH, Hu X, Galvan A, Basu J, Michaelides M, Sternson SM.

Science. 2019 Apr 12;364(6436). pii: eaav5282. doi: 10.1126/science.aav5282. Epub 2019 Mar 14.

PMID:
30872534
4.

The DNA repair transcriptome in severe COPD.

Sauler M, Lamontagne M, Finnemore E, Herazo-Maya JD, Tedrow J, Zhang X, Morneau JE, Sciurba F, Timens W, Paré PD, Lee PJ, Kaminski N, Bossé Y, Gomez JL.

Eur Respir J. 2018 Oct 4;52(4). pii: 1701994. doi: 10.1183/13993003.01994-2017. Print 2018 Oct.

5.

Reducing protein oxidation reverses lung fibrosis.

Anathy V, Lahue KG, Chapman DG, Chia SB, Casey DT, Aboushousha R, van der Velden JLJ, Elko E, Hoffman SM, McMillan DH, Jones JT, Nolin JD, Abdalla S, Schneider R, Seward DJ, Roberson EC, Liptak MD, Cousins ME, Butnor KJ, Taatjes DJ, Budd RC, Irvin CG, Ho YS, Hakem R, Brown KK, Matsui R, Bachschmid MM, Gomez JL, Kaminski N, van der Vliet A, Janssen-Heininger YMW.

Nat Med. 2018 Aug;24(8):1128-1135. doi: 10.1038/s41591-018-0090-y. Epub 2018 Jul 9.

6.

Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity.

Michaelides M, Miller ML, Egervari G, Primeaux SD, Gomez JL, Ellis RJ, Landry JA, Szutorisz H, Hoffman AF, Lupica CR, Loos RJF, Thanos PK, Bray GA, Neumaier JF, Zachariou V, Wang GJ, Volkow ND, Hurd YL.

Mol Psychiatry. 2018 Jun 28. doi: 10.1038/s41380-018-0120-7. [Epub ahead of print]

7.

Iron deficiency in chronic kidney disease patients with diabetes mellitus.

Robles NR, Ramos JL, Chavez E, Gonzalez Candia B, Bayo MA, Cidoncha A, Gomez JL, Cubero JJ.

Diabetes Metab Syndr. 2018 Nov;12(6):933-937. doi: 10.1016/j.dsx.2018.05.018. Epub 2018 May 22.

PMID:
29804918
8.

On the first occupational medicine initiatives in Mexico: The Real del Monte miners’ hospital.

Gómez JL, Rodríguez-Paz CA.

Gac Med Mex. 2018;154(2):263-266. doi: 10.24875/GMM.18002438. Spanish.

9.

Characterization of Sex-Based Dna Methylation Signatures in the Airways During Early Life.

Nino CL, Perez GF, Isaza N, Gutierrez MJ, Gomez JL, Nino G.

Sci Rep. 2018 Apr 3;8(1):5526. doi: 10.1038/s41598-018-23063-5.

10.

Impaired type I interferon regulation in the blood transcriptome of recurrent asthma exacerbations.

Gomez JL, Diaz MP, Nino G, Britto CJ.

BMC Med Genomics. 2018 Feb 27;11(1):21. doi: 10.1186/s12920-018-0340-3.

11.

Blazar spectral variability as explained by a twisted inhomogeneous jet.

Raiteri CM, Villata M, Acosta-Pulido JA, Agudo I, Arkharov AA, Bachev R, Baida GV, Benítez E, Borman GA, Boschin W, Bozhilov V, Butuzova MS, Calcidese P, Carnerero MI, Carosati D, Casadio C, Castro-Segura N, Chen WP, Damljanovic G, D'Ammando F, Di Paola A, Echevarría J, Efimova NV, Ehgamberdiev SA, Espinosa C, Fuentes A, Giunta A, Gómez JL, Grishina TS, Gurwell MA, Hiriart D, Jermak H, Jordan B, Jorstad SG, Joshi M, Kopatskaya EN, Kuratov K, Kurtanidze OM, Kurtanidze SO, Lähteenmäki A, Larionov VM, Larionova EG, Larionova LV, Lázaro C, Lin CS, Malmrose MP, Marscher AP, Matsumoto K, McBreen B, Michel R, Mihov B, Minev M, Mirzaqulov DO, Mokrushina AA, Molina SN, Moody JW, Morozova DA, Nazarov SV, Nikolashvili MG, Ohlert JM, Okhmat DN, Ovcharov E, Pinna F, Polakis TA, Protasio C, Pursimo T, Redondo-Lorenzo FJ, Rizzi N, Rodriguez-Coira G, Sadakane K, Sadun AC, Samal MR, Savchenko SS, Semkov E, Skiff BA, Slavcheva-Mihova L, Smith PS, Steele IA, Strigachev A, Tammi J, Thum C, Tornikoski M, Troitskaya YV, Troitsky IS, Vasilyev AA, Vince O.

Nature. 2017 Dec 21;552(7685):374-377. doi: 10.1038/nature24623. Epub 2017 Dec 4.

PMID:
29211720
12.

Characterisation of asthma subgroups associated with circulating YKL-40 levels.

Gomez JL, Yan X, Holm CT, Grant N, Liu Q, Cohn L, Nezgovorova V, Meyers DA, Bleecker ER, Crisafi GM, Jarjour NN, Rogers L, Reibman J, Chupp GL; SARP Investigators.

Eur Respir J. 2017 Oct 12;50(4). pii: 1700800. doi: 10.1183/13993003.00800-2017. Print 2017 Oct.

13.

Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.

Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, Ellis RJ, Richie CT, Harvey BK, Dannals RF, Pomper MG, Bonci A, Michaelides M.

Science. 2017 Aug 4;357(6350):503-507. doi: 10.1126/science.aan2475.

PMID:
28774929
14.

Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement.

Michaelides M, Miller ML, DiNieri JA, Gomez JL, Schwartz E, Egervari G, Wang GJ, Mobbs CV, Volkow ND, Hurd YL.

Neuropsychopharmacology. 2017 Nov;42(12):2365-2376. doi: 10.1038/npp.2017.112. Epub 2017 Jun 5.

15.

Chronic Obstructive Pulmonary Disease Readmissions and Other Measures of Hospital Quality.

Rinne ST, Castaneda J, Lindenauer PK, Cleary PD, Paz HL, Gomez JL.

Am J Respir Crit Care Med. 2017 Jul 1;196(1):47-55. doi: 10.1164/rccm.201609-1944OC.

16.

Toward Precision Medicine of Symptom Control in Asthma.

Gomez JL, Kaminski N.

Am J Respir Crit Care Med. 2017 Jan 15;195(2):147-148. doi: 10.1164/rccm.201608-1600ED. No abstract available.

17.

Airway Secretory microRNAome Changes during Rhinovirus Infection in Early Childhood.

Gutierrez MJ, Gomez JL, Perez GF, Pancham K, Val S, Pillai DK, Giri M, Ferrante S, Freishtat R, Rose MC, Preciado D, Nino G.

PLoS One. 2016 Sep 19;11(9):e0162244. doi: 10.1371/journal.pone.0162244. eCollection 2016.

18.

Hypogonadotropic Hypogonadism and Short Stature in Patients with Diabetes Due to Neurogenin 3 Deficiency.

Rubio-Cabezas O, Gómez JL, Gleisner A, Hattersley AT, Codner E.

J Clin Endocrinol Metab. 2016 Oct;101(10):3555-3558. Epub 2016 Aug 17.

19.

National Heart, Lung, and Blood Institute Workshop Summary: Enhancing Opportunities for Training and Retention of a Diverse Biomedical Workforce.

Duncan GA, Lockett A, Villegas LR, Almodovar S, Gomez JL, Flores SC, Wilkes DS, Tigno XT.

Ann Am Thorac Soc. 2016 Apr;13(4):562-7. doi: 10.1513/AnnalsATS.201509-624OT.

20.

Guillain-Barré syndrome mimics primary biliary cirrhosis-related myopathy.

Munday WR, DiCapua D, Vortmeyer A, Gomez JL.

Oxf Med Case Reports. 2015 Apr 23;2015(4):272-5. doi: 10.1093/omcr/omv033. eCollection 2015 Apr.

21.

Differential effects of ghrelin antagonists on alcohol drinking and reinforcement in mouse and rat models of alcohol dependence.

Gomez JL, Cunningham CL, Finn DA, Young EA, Helpenstell LK, Schuette LM, Fidler TL, Kosten TA, Ryabinin AE.

Neuropharmacology. 2015 Oct;97:182-93. doi: 10.1016/j.neuropharm.2015.05.026. Epub 2015 Jun 4.

22.

Genetic variation in chitinase 3-like 1 (CHI3L1) contributes to asthma severity and airway expression of YKL-40.

Gomez JL, Crisafi GM, Holm CT, Meyers DA, Hawkins GA, Bleecker ER, Jarjour N; Severe Asthma Research Program (SARP) Investigators, Cohn L, Chupp GL.

J Allergy Clin Immunol. 2015 Jul;136(1):51-58.e10. doi: 10.1016/j.jaci.2014.11.027. Epub 2015 Jan 13.

23.

The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL/6J mice.

Gomez JL, Ryabinin AE.

Alcohol Clin Exp Res. 2014 Sep;38(9):2436-44. doi: 10.1111/acer.12499.

24.

Neurogenin 3 is important but not essential for pancreatic islet development in humans.

Rubio-Cabezas O, Codner E, Flanagan SE, Gómez JL, Ellard S, Hattersley AT.

Diabetologia. 2014 Nov;57(11):2421-4. doi: 10.1007/s00125-014-3349-y. Epub 2014 Aug 14. No abstract available.

25.
26.

Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.

Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Gilbert L, Martel C, Balser J.

J Sex Med. 2014 Jul;11(7):1766-85. doi: 10.1111/jsm.12517. Epub 2014 Apr 28.

PMID:
24774442
27.

Study of different reaction schemes for the enzymatic synthesis of polyglycerol polyricinoleate.

Ortega-Requena S, Gómez JL, Bastida J, Máximo F, Montiel MC, Murcia MD.

J Sci Food Agric. 2014 Aug;94(11):2308-16. doi: 10.1002/jsfa.6559. Epub 2014 Feb 22.

PMID:
24403129
28.

Female rats exposed to stress and alcohol show impaired memory and increased depressive-like behaviors.

Gomez JL, Luine VN.

Physiol Behav. 2014 Jan 17;123:47-54. doi: 10.1016/j.physbeh.2013.09.009. Epub 2013 Oct 1.

29.

Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.

Labrie F, Martel C, Bérubé R, Côté I, Labrie C, Cusan L, Gomez JL.

J Steroid Biochem Mol Biol. 2013 Nov;138:359-67. doi: 10.1016/j.jsbmb.2013.08.002. Epub 2013 Aug 14.

PMID:
23954500
30.

Hypocalcemia in a paediatric case: from the clinical features to diagnosis.

Gómez JL, Momblán JJ, Ibáñez MM, Pérez MJ, Garzón MI, Martínez G, Alcalde M.

J Pediatr Endocrinol Metab. 2014 Jan;27(1-2):139-42. doi: 10.1515/jpem-2013-0149.

PMID:
23934640
31.

Deep venous thrombosis: prevention and management.

Iverson RE, Gomez JL.

Clin Plast Surg. 2013 Jul;40(3):389-98. doi: 10.1016/j.cps.2013.04.002. Review.

PMID:
23830747
32.

Exposure of Bacillus subtilis to mercury induces accumulation of shorter tRNA Cys species.

Cruz Hernández A, Millan ES, de Jesús Romero Gómez S, Antonio Cervantes Chávez J, Garcia Martínez R, Pastrana Martínez X, Gómez JL, Jones GH, Guillén JC.

Metallomics. 2013 Apr;5(4):398-403. doi: 10.1039/c3mt20203h.

PMID:
23529473
33.

Alcohol administration blocks stress-induced impairments in memory and anxiety, and alters hippocampal neurotransmitter receptor expression in male rats.

Gomez JL, Lewis MJ, Sebastian V, Serrano P, Luine VN.

Horm Behav. 2013 Apr;63(4):659-66. doi: 10.1016/j.yhbeh.2013.01.007. Epub 2013 Feb 1.

34.

Poor response to antiplatelet drugs. An important issue in drug-eluting stents.

Del Castillo-Carnevali H, Alonso VB, Sabán-Ruiz J, Gómez JL.

Curr Clin Pharmacol. 2013 Nov;8(4):340-9. Review.

PMID:
23173959
35.

Removal efficiency and toxicity reduction of 4-chlorophenol with physical, chemical and biochemical methods.

Gómez M, Murcia MD, Dams R, Christofi N, Gómez E, Gómez JL.

Environ Technol. 2012 Apr-May;33(7-9):1055-64.

PMID:
22720434
36.

The interaction of chronic restraint stress and voluntary alcohol intake: effects on spatial memory in male rats.

Gomez JL, Lewis MJ, Luine VN.

Alcohol. 2012 Aug;46(5):499-504. doi: 10.1016/j.alcohol.2011.12.005. Epub 2012 May 2.

37.

Behaviour of RO98pHt polyamide membrane in reverse osmosis and low reverse osmosis conditions for phenol removal.

Hidalgo AM, León G, Gómez M, Murcia MD, Gómez E, Gómez JL.

Environ Technol. 2011 Oct;32(13-14):1497-502.

PMID:
22329140
38.

Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia.

Labrie F, Archer DF, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.

Climacteric. 2011 Apr;14(2):282-8. doi: 10.3109/13697137.2010.535226. Epub 2011 Jan 18.

PMID:
21244215
39.

High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy.

Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Martel C, Balser J.

Gynecol Endocrinol. 2010 Jul;26(7):524-32. doi: 10.3109/09513590903511547.

PMID:
20459349
40.

Quality indicators for the prevention of type 2 diabetes in Europe--IMAGE.

Pajunen P, Landgraf R, Muylle F, Neumann A, Lindström J, Schwarz PE, Peltonen M, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T.

Horm Metab Res. 2010 Apr;42 Suppl 1:S56-63. doi: 10.1055/s-0029-1240976. Epub 2010 Apr 13.

41.

Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe.

Lindström J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U, Pajunen P, Puhl S, Pölönen A, Rissanen A, Roden M, Stemper T, Telle-Hjellset V, Tuomilehto J, Velickiene D, Schwarz PE, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T.

Horm Metab Res. 2010 Apr;42 Suppl 1:S37-55. doi: 10.1055/s-0029-1240975. Epub 2010 Apr 13.

PMID:
20391307
42.

A European evidence-based guideline for the prevention of type 2 diabetes.

Paulweber B, Valensi P, Lindström J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, Sheppard KE, Charlesworth K, Felton AM, Hall M, Rissanen A, Tuomilehto J, Schwarz PE, Roden M, Paulweber M, Stadlmayr A, Kedenko L, Katsilambros N, Makrilakis K, Kamenov Z, Evans P, Gilis-Januszewska A, Lalic K, Jotic A, Djordevic P, Dimitrijevic-Sreckovic V, Hühmer U, Kulzer B, Puhl S, Lee-Barkey YH, AlKerwi A, Abraham C, Hardeman W, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T.

Horm Metab Res. 2010 Apr;42 Suppl 1:S3-36. doi: 10.1055/s-0029-1240928. Epub 2010 Apr 13.

43.

Assisted reproductive technologies in public and private clinics.

Castilla JA, Hernandez E, Cabello Y, Navarro JL, Hernandez J, Gomez JL, Pajuelo N, Marqueta J, Coroleu B.

Reprod Biomed Online. 2009 Dec;19(6):872-8.

PMID:
20031031
44.

Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).

Echeverría P, Negredo E, Carosi G, Gálvez J, Gómez JL, Ocampo A, Portilla J, Prieto A, López JC, Rubio R, Mariño A, Pedrol E, Viladés C, del Arco A, Moreno A, Bravo I, López-Blazquez R, Pérez-Alvarez N, Clotet B.

Antiviral Res. 2010 Feb;85(2):403-8. doi: 10.1016/j.antiviral.2009.11.008. Epub 2009 Nov 24.

PMID:
19941906
45.

Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.

Sánchez-Morla EM, Barabash A, Martínez-Vizcaíno V, Tabarés-Seisdedos R, Balanzá-Martínez V, Cabranes-Díaz JA, Baca-Baldomero E, Gómez JL.

Psychiatry Res. 2009 Oct 30;169(3):220-8. doi: 10.1016/j.psychres.2008.06.032. Epub 2009 Sep 15.

PMID:
19758705
46.

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.

Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Bérubé R, Bélanger P, Berger L, Gilbert L, Martel C, Balser J.

Menopause. 2009 Sep-Oct;16(5):897-906. doi: 10.1097/gme.0b013e31819e8930.

PMID:
19436226
47.

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.

Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.

Menopause. 2009 Sep-Oct;16(5):907-22. doi: 10.1097/gme.0b013e31819e8e2d.

PMID:
19436225
48.

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.

Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.

Menopause. 2009 Sep-Oct;16(5):923-31. doi: 10.1097/gme.0b013e31819e85c6.

PMID:
19424093
49.

Comparison of alternative treatments for 4-chlorophenol removal from aqueous solutions: use of free and immobilized soybean peroxidase and KrCl excilamp.

Gomez M, Matafonova G, Gomez JL, Batoev V, Christofi N.

J Hazard Mater. 2009 Sep 30;169(1-3):46-51. doi: 10.1016/j.jhazmat.2009.03.059. Epub 2009 Mar 21.

PMID:
19361921
50.

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR).

Olivares JM, Rodriguez-Morales A, Diels J, Povey M, Jacobs A, Zhao Z, Lam A, Villalobos Vega JC, Cuéllar JA, de Castro FJ, Quintero CM, Martíin JF, Domínguez P, Ojeda JL, Cortés SS, Cala FI, Marín CG, Castro LM, Duaso MA, Albarracín JR, Vergara GN, Benítez AF, Cleries FM, Pérez-Brian JM, Aragón AB, Navarro JC, Biedma JA, de Pedro RB, González JF, López ME, Moreno HD, López JA, Rodríguez EO, de Hoyos CM, Sacristán MP, Martín MD, Ballesteros EM, Rodríguez PA, Menéndez LF, Rivas RS, del Pino Cuadrado P, Lauffer JC, Solano JJ, Martínez JM, Solano FG, Rodríguez PG, Rodríguez JA, Cano TR, Fortacin MD, Lobeiras JM, Sampedro JM, Bravo AP, Pellicer AF, López MD, Liste JF, Fernández MR, Losada AC, Mendez RV, Romero SA, Blanco JJ, Bonaselt IT, Mahia MC, del Valle EF, Yañez PQ, Camarasa MG, Alonso JA, Mendez GF, Feliz FD, Lamela MA, Piñero MV, Alvarado PF, Gómez IL, Martín PF, Gómez JL, López AG, Jiménez AR, Nafs AE, Barquero NC, Ortiz RF, Noguera JL, Carrasco PR, Muñoz JM, Palma MM, Hortelano CM, Bonome LS, Sevilla JS, Juan JM, Ramos JM, Muñoz JL, Guisasola JE, Vazquez LS, Guerras FC, Nebot FJ, Fernández FJ, Nicolau AL, Subirats RC, Kidias MM, Navarro VF, García BF, del Rosal FM, de Vicente Muñoz T, Ballester JA, Lieb PM, Martel AD, Bea ER, Joaquim IG, Enjuanes FB, Piñol MB, Carbonell EF, Muñoz RM, Giribets CA, Sans LA, Blanco AS, Felipe MA, Muñoz PG, Villanueva AP, Arroyo MB, Borri RC, Fallada SM, Merola MC, Rodon EP, Palmes JR, Martínez EP, Catala JM, Coca AS, Ferrandiz FP, Paya EF, Caballero GI, Bonet AF, Figueras JF, Pagador PM, Garibo MM, Camo VP, Carrillo CS, Valero CP, Rebollo FJ, García Campayo J, Sala Ayma JM, Roig MM, de Uña Mateos MA, Bertolin RG, García AM, Mazo FJ, Velasco JL, Pérez LS, Casado CJ, Barba JJ, Diaz MC, Rubio JP, Mandoli AS, Herrero AU, Martínez AR, Serrano PS, Rodríguez EN, Montesinos JS, Macia JF, Mateos Marcos AM, Soto JV, Dumont MV, Pagan JP, Martínez VB, Santiuste de Pablos M, Delgado CE, Quiles MD, López FJ, Navarro PP, Torres AM, Ingles FJ, Arias-Camison JM, Manzano JC, Peña RV, Guitarte GP, Fontecilla HB, Romero JB, Gil RS, Lozano JM, Adanez LD, Zarranz Herrera-Oria I, Jiménez JP, Vaz FC, García OS, Anton CC, Casula RR, Hernandez MC, Escabias FT, Torresano JR, Pérez-Villamil AH, Estevez L, Figuero MA, Muñoz de Morales A, Calvin JL, Criado MD, Rodríguez VM, Ambrosolio EB, Madera PM, Alfaro GP, Vidal MM, Valtuille AG, Ruiz O, Cabornero GL, Echevarria Martínez de Bujo M, Mallen MJ, Puigros JS, Martorell AL, Forteza AC, Arrebola ER, Rodríguez de la Torre M, Saiz CG, Bardolet I Casas C, Linde ER, De Arce Cordon R, Molina EM, Carazo FJ, Romero JJ, Cano DV, Dorado MS, Velazquez SC, Sánchez AJ, Leon SO, Sánchez KP, Benitez MH, Zugarramurai AI, Contreras MA, De la Varga González M, Marín PB, Robina FG, García MS, Pérez FJ, Bros PC, Gómez AC, de Dios Molina Martín J, Perera JL, Averbach MC, Perera JL, Palancares EG, Gallego de Dios MT, Rojo CF, Iglesias SS, Merino MI, Mestre NP, Urdaniz AP, Sánchez JM, Seco RG, Muñoz JF, Agut MM, Lozano ML, Herguedas FM, Pena AT, García JV, Martínez AV, Sanz Granado OS, Fernández MA, Canseco JM, López PA, Martín MA, Barrio JA, Ubago JG, Bennassar MR, Díez JM, Fleta JL, Fortes FP, López CA, Medina O, Alvarez DF, Roca JM, Valladolid GR, Tavera JA, García-Castrillon Sales JA, Llordes IB, Melgarejo CA, Cañas de la Paz F, Callol VV, García MB, García JB, Leal FJ, Corrales EC, Iglesias ES, Gómez MA, Serrano GG, Chillarón EG, Aguado FJ, Castillo JJ, González AG, Vázquez JG, Peralvarez MB, Diaz MR, Mesa MY, Artiles FJ, Chao MA, Mesa MY, del Rosario Santana P, Escudero MA, Berenguer MM, Llacer JM, Berna JA, Ortiz JB, Pardell LT, Hernández-Alvarez de Sotomayor C, Méndez MR, Garate RC, Múgica BD, González MC, Domingo JP, Navarro CS, Vera GS, Cuquerella MA, Monzo JL, Boada PC, Pérez MF, Parrado EC, Sánchez JJ, Fernández JC; e-STAR Spanish Study Group.

Eur Psychiatry. 2009 Jun;24(5):287-96. doi: 10.1016/j.eurpsy.2008.12.002. Epub 2009 Feb 4.

PMID:
19195847

Supplemental Content

Loading ...
Support Center